About this Medicine article
Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells by Terp, Mikkel G. (author);Jacobsen, Kirstine (author);Molina, Miguel Angel (author);Karachaliou, Niki (author);Beck, Hans C. (author);Bertran-Alamillo, Jordi (author);Giménez-Capitán, Ana (author);Cardona, Andrés F. (author);Rosell, Rafael (author);Ditzel, Henrik J. (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Terp, Mikkel G. (author);Jacobsen, Kirstine (author);Molina, Miguel Angel (author);Karachaliou, Niki (author);Beck, Hans C. (author);Bertran-Alamillo, Jordi (author);Giménez-Capitán, Ana (author);Cardona, Andrés F. (author);Rosell, Rafael (author);Ditzel, Henrik J. (author)
- Publisher
- Springer Science and Business Media LLC
- Published
- 2021
- Field
- Medicine (Health Sciences)